Lumohs was built to solve a problem clinicians have quietly accepted for decades.

Clinicians and staff routinely handle exposed surgical blades.

For more than 30 years, Dr. Steven Hacker has run a busy clinical practice where minor procedures were performed every day. Over that time, he repeatedly saw trained medical assistants and nurses injure themselves while handling razor-sharp blades.

1. Cuts to the hands.
2. Blood exposure.
3. Trips to urgent care or the ER.
4. Lost workdays and liability for clinics.

These incidents were rarely treated as extraordinary. They were accepted as part of the job.

At the same time, procedural visibility during many minor procedures remains limited. Lighting is often inconsistent, obstructed by hand shadowing, prohibitively expensive, or unavailable in many real-world environments.

When procedures are performed millions of times each year, these risks add up quickly. Yet the core instrument used in these workflows, the handle, has barely evolved. Blade loading remains manual.

We eliminate an entire line cost item.

Savings huge. Safety Improved.

Before Lumohs hospitals, clinics, doctor's offices to be compliant with OSHA and minimize risks of blade related injuries they need to buy, install and replace blade removers. This cost is completely gone as we built the blade loader and remover into the process. GONE. Saving all customers thousands on a safer better more efficient process.

When injuries occur, the impact extends far beyond the individual incident. Hand lacerations and blood exposure translate into lost staff time, disrupted schedules, workers’ compensation claims, urgent care visits, and administrative overhead. Even minor injuries can remove trained personnel from the floor, slow patient throughput, and introduce operational friction into otherwise routine procedures.

These injuries are not the result of complex medical decisions— they occur during interaction with exposed blades.

Across high-volume practices these inefficiencies compound. Clinics lose productivity, incur avoidable costs, and accept slower patient turnover because the underlying tools were never designed with safety and visibility as integrated system requirements.

The workflow problem hiding in plain sight

High-volume procedures across aesthetics, dermatology, and minor surgery still rely on manual blade handling. Professionals are required to load and eject exposed blades by hand, creating an unavoidable occupational risk.

At the same time, limited illumination and hand shadowing reduce visibility at the point of care, increasing the likelihood of imprecision during routine procedures.

Despite the scale of these procedures, the tools used in these workflows have changed very little. The handle itself has become commoditized, and meaningful innovation has stalled.

Redesigning the system, not the behavior

The Lumohs team approaches the problem differently. Rather than improving a single component, Lumohs redesigns the workflow itself.

First, blade handling risk is eliminated. Manual loading and ejection are replaced with a touchless cartridge system that removes direct contact with exposed blades.

Second, provider visibility is enhanced. Illumination is integrated directly into the instrument, delivering consistent, on-axis light to the point of care.

Not Cliche. We Really Are "A Razor: Razor Blade" Business.

The result is a safer, faster, and more consistent workflow that fits seamlessly into existing clinical practice. Clinicians do not need to change how they work. They simply work with a better system.

A platform built for durability and scale

Lumohs is not a single device. It is a vertically integrated platform that combines proprietary hardware, patented consumables, and software-enabled workflows.

Hardware enables adoption. Proprietary cartridges create repeat usage. Software supports training and procedural consistency. Together, these elements transform a historically commoditized instrument into a scalable platform with recurring usage.

Past Prototypes. Commercially Shipping Today.

Lumohs is designed not only as a procedural tool but as a connected platform.

From Device to Connected Platform

Future versions of the device integrate Bluetooth connectivity with a mobile application and cloud data infrastructure. During a dermaplaning session, the device can capture procedural telemetry such as blade angle, motion patterns, stroke cadence, session duration, and lighting settings.

This vector information can be paired with AI facial images performed before and after treatments. Over time this creates a unique dataset linking dermaplaning technique with measurable skin results.

This data can support practitioner feedback, training tools, and outcome-based skincare insights while helping standardize technique across industry.

We call this intelligence layer Vector Intelligence. It's the AI engine that will predict skin outcomes from technique data and coach practitioners in real time — turning dermaplaning from an artisanal skill into a measurable, teachable technique. Vector Intelligence is in development today, launching on Gen 2 hardware and growing more valuable as our install base expands. Every procedure makes the model smarter. Every new clinic widens the lead.

Example: GlowScore

Lumohs is developing a simple performance metric called GlowScore.

GlowScore converts dermaplaning session data and measured skin outcomes into an easy-to-understand score that reflects both technique quality and skin improvement.

For practitioners, this provides feedback and training insights.

For clients, it creates a measurable way to track skin improvement over time.

GlowScore represents one example of how connected devices and outcome measurement can transform dermaplaning into a measurable procedure rather than an artisanal technique.

Why aesthetics is the starting point:

Hear directly from the founder, Dr. Steven Hacker alongside leading esthetician instructors (and watch Lumohs in action in the video below).

Dermaplaning is now a standard component of professional facials across the United States. Approximately 150,000 licensed estheticians perform roughly 150,000 dermaplaning procedures each day, before accounting for all other surgical use. That represents an enormous number of blade-handling events occurring daily.

The Lumohs team chose aesthetics as the entry market because it combines high procedure volume with rapid adoption of new professional tools. From this foundation, the same platform expands naturally into dermatology, surgery, emergency medicine, and defense applications.

Initial Reviews of Gen 2 Handle

Importantly, Lumohs was designed from the outset as a touchless blade-handling platform, not a single-use cosmetic tool. While Nano Surgical remains focused on professional aesthetics today, this design creates long-term enterprise optionality, including potential relevance in robotic and hybrid surgical settings, without changes to our current roadmap.

Why Now

Several industry shifts make this the right moment to modernize procedural tools. The aesthetics market has grown rapidly over the past decade, and dermaplaning is now a routine procedure performed hundreds of thousands of times each day.

Clinics and medical practices are increasingly focused on occupational safety and work flow efficiency, particularly as staffing shortages make injuries and lost workdays more costly.

At the same time, connected devices and measurable outcomes are becoming standard expectations across healthcare and professional beauty.

Advances in electronics miniaturization, mobile software, and manufacturing now make it possible to integrate illumination, connectivity, and analytics directly into handheld instruments.

Together these shifts create a clear opportunity to modernize a tool that has remained largely unchanged for decades.

Revenue strategy and milestones.

The Lumohs platform has already demonstrated real-world demand with real-world execution.

Over 2,400 units — handles, batteries, and accessories — have been sold through five wholesale distributors and direct-to-practitioner retail, with little to zero marketing spend. Second-generation platform is launching May 2026 with pre-order demand from existing customers. Manufacturing, regulatory pathways, and operational infrastructure are now established.

Nano Surgical is no longer searching for product-market fit. The focus is now on scaling production, expanding distribution, and increasing recurring consumable usage.

In 2025, we made a deliberate choice. After proving product-market fit with our first-generation device, we redirected every resource into building the second-generation platform — launching May 2026 and funded by this round. The revenue dip and net loss are the shape of that decision: R&D, tooling, IP, and regulatory work instead of chasing more MVP sales. We chose to build the next product rather than squeeze the last one.

Real products. Real brand. Really Online.

The next phase of growth builds on the existing platform.

A key milestone is the upcoming Single-Use Lumohs Sterile Handle, designed for environments where reusable tools are impractical or not permitted. These environments include clinics, emergency response, military medicine, and field medical settings where disposable workflows are required and lighting is often limited.

Single-use Platform- Designed for military applications, surgical kits for trauma & emergency care (night vision needed).

Lumohs can serve these environments while maintaining the same touchless blade-handling system and integrated illumination.

Defensibility rooted in design and execution

Nano Surgical has built a defensible ecosystem around the Lumohs platform. The company holds more than 25+ patents (12+ issued, 12 pending) , primarily utility patents, covering blade loading mechanisms, illumination systems and cartridge architecture. By controlling both the hardware and the proprietary consumables that enable the system, Nano Surgical creates a durable competitive advantage that is difficult to replicate.

Beyond hardware and consumables, Nano Surgical is building a data moat. Technique telemetry paired with before-and-after skin scans creates a proprietary dataset no competitor can replicate without owning the hardware layer — and Vector Intelligence turns that dataset into a compounding advantage that strengthens with every procedure performed on the platform.

Made in USA

Vertically integrated from day one.

Nano Surgical owns the molds, the tooling, and all device designs outright. This gives Nano Surgical full control over production quality, cost structure and the ability to iterate rapidly without dependency on third party IP.

Our FDA compliant U.S. manufacturing partner produces every device domestically - supporting regulatory alignment and quality standards.

Founder-market fit at the center

Lumohs exists because its founder experienced the problem firsthand.

Dr. Steven Hacker is a dermatologist with more than 30 years of clinical experience who built the product he wanted to use in his own practice. That clinical perspective informs the design, safety priorities, and practical realities of adoption.

Why the Lumohs team chose Wefunder

Wefunder allows Nano Surgical to align its customer with its long-term mission. Practitioners understand this problem directly because they experience it every day. By giving clinicians and users the opportunity to become shareholders, the company builds a community that is financially and operationally invested in the platform's success.

Use of capital

Capital from this round will be used to:

1. expand manufacturing inventory tooling,
2. increase production capacity,
3. scale distribution and go-to-market execution,
4. continue development of the Lumohs platform.

Looking ahead

Nano Surgical is building a future where procedural safety, visibility, and intelligence are designed directly into the tools clinicians use every day. Touchless blade handling, integrated illumination, and Vector Intelligence turn millions of routine procedures into a compounding data advantage.

By combining touchless blade handling with integrated illumination, Lumohs improves safety and visibility across millions of procedures performed each year.

The company is now scaling manufacturing, expanding distribution and growing the Lumohs Platform.

Invest in Nano Surgical and help modernize procedural safety.